Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115844 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wooyeol Baek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic & Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Keloid, Fibroblasts, Pyruvates, Spheroids, Cellular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: L&C Bio Inc, L&C Bio Inc..
Abstract (Originalsprache)
Keloids, marked by abnormal cellular proliferation and excessive extracellular matrix (ECM) accumulation, pose significant therapeutic challenges. Ethyl pyruvate (EP), an inhibitor of the high-mobility group box 1 (HMGB1) and TGF-β1 pathways, has emerged as a potential anti-fibrotic agent. Our research evaluated EP’s effects on keloid fibroblast (KF) proliferation and ECM production, employing both in vitro cell cultures and ex vivo patient-derived keloid spheroids. We also analyzed the expression levels of ECM components in keloid tissue spheroids treated with EP through immunohistochemistry. Findings revealed that EP treatment impedes the nuclear translocation of HMGB1 and diminishes KF proliferation. Additionally, EP significantly lowered mRNA and protein levels of collagen I and III by attenuating TGF-β1 and pSmad2/3 complex expression in both human dermal fibroblasts and KFs. Moreover, metalloproteinase I (MMP-1) and MMP-3 mRNA levels saw a notable increase following EP administration. In keloid spheroids, EP induced a dose-dependent reduction in ECM component expression. Immunohistochemical and western blot analyses confirmed significant declines in collagen I, collagen III, fibronectin, elastin, TGF-β, AKT, and ERK 1/2 expression levels. These outcomes underscore EP’s antifibrotic potential, suggesting its viability as a therapeutic approach for keloids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic & Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Bioengineering, College of Engineering, Hanyang University, Seoul 04763, Republic of Korea.
- Institute of Nano Science and Technology (INST), Hanyang University, Seoul 04763, Republic of Korea.
ORCID-Profile: Wooyeol Baek, Chae-Ok Yun
Förderung
- L&C Bio Inc
- L&C Bio Inc.
Zitieren
APA
Baek, W., Park, S., Lee, Y., Roh, H., Yun, C. O., Roh, T. S., & Lee, W. J. (2024). Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115844
Vancouver
Baek W, Park S, Lee Y, Roh H, Yun CO, Roh TS, et al. Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115844
BibTeX
@article{Baek2024,
author = {Baek, Wooyeol and Park, Seonghyuk and Lee, Youngdae and Roh, Hyun and Yun, Chae-Ok and Roh, Tai Suk and Lee, Won Jai},
title = {Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115844}
}
EUVIMED